Discount discount.....research aarkstore enterprise molecular diagnostics in infectious disease testing


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Discount discount.....research aarkstore enterprise molecular diagnostics in infectious disease testing

  1. 1. discount discount.....ResearchAarkstore Enterprise Molecular Diagnostics in Infectious Disease Testing TriMark Publications report describes the specific segment of the in vitro diagnostics marketknown as molecular diagnostics testing for infectious disease. In the current medical diagnosticsmarket, molecular diagnostics in infectious disease testing offers one of the most promisingareas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in the blood--has led tothis revolutionary market development. Specifically, molecular diagnostics offers the power ofadvanced analytical techniques to diagnose infectious diseases. Whereas before, the detectionof many infectious agents was slow and expensive due to reliance upon culturing methods,researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing. The purpose of this report is to describe the emergingfield of molecular diagnostics in infectious disease testing. The infectious disease space is themost dominant and profitable sector of molecular diagnostics. Topics covered in this studyinclude: 1) the existing and emerging technologies in the field, 2) the U.S. and global market sizefor molecular diagnostic products and 3) the profiles of companies that are focusing on themolecular diagnostic sector. The research examines drivers and restraints for sales growth,market share and technical trends. In addition, an in-depth analysis of the competitive situationof prominent market venders is provided with five-year sales forecasts.Table of Contents :1. Overview 141.1 Statement of Report 141.2 About This Report 151.3 Scope of the Report 151.4 Objectives 17
  2. 2. 1.5 Methodology 171.6 Executive Summary 192. Introduction to Molecular Diagnostics for Infectious Disease Testing 272.1 Molecular Diagnostics Testing and Opportunities in the Infectious Disease Sector 272.2 The Infectious Disease Problem 312.3 Impact of the Human Genome Project on Molecular Diagnostics 352.4 Opportunities for Molecular and Clinical Diagnostics 352.4.1 Companion Diagnostics 362.5 Development of Molecular Diagnostics Testing Markets 372.6 Target-based Gene Amplification 382.6.1 Polymerase Chain Reaction (PCR) 382.6.2 Real-time PCR (RT-PCR) 392.6.3 Nucleic Acid Sequence-based Amplification (NASBA) 392.6.4 Market Drivers and Restraints 462.6.4.1 Market Drivers 462.6.4.2 Market Restraints 462.6.5 Market and Technology Trends 462.6.5.1 Market Trends 462.6.5 2 Technology Trends 472.6.6 Strategic Recommendations 472.7 PCR Reagents for Clinical Diagnostics 483. Infectious Disease Diagnostics Molecular Testing Market 503.1 Market Overview 503.1.1 Overall Infectious Disease Market Analysis 53
  3. 3. 3.2 NAT Molecular Diagnostics Market 653.3 Infectious Disease Molecular Diagnostic Testing Markets 663.3.1 HIV 663.3.1.1 Disease Background and Statistics 663.3.1.2 Measuring Viral Loads 743.3.1.3 Instruments and MD Reagents 753.3.1.4 Method Comparisons 81For more information please visit link: EnterprisePhone:08149852585Email:enquiry@aarkstore.comURL:www.aarkstore.com Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, BusinessTrends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets
  4. 4. Diabetes, Metabolic Syndrome and Cardiovascular DiseaseCatheter MarketsBlood Glucose Testing and Diabetes ManagementGlobal Flow Cytometry MarketU.S. Glucose Testing MarketsHigh-Growth Diagnostic Testing MarketsEuropean Point of Care Diagnostic Testing MarketsDisposable Syringe MarketsPoint of Care Diagnostic Testing World MarketsDisposable Medical Supplies MarketsMolecular Diagnostics in Infectious Disease TestingCompanion Diagnostics in Personalized Medicine and Cancer TherapyWorld Glucose Self-Testing MarketsVeterinary Health MarketsPoint of Care Diagnostic Testing Sector TrendsCardiac Marker Diagnostic Testing MarketsMass Spectroscopy for Clinical Laboratory AnalysisCardiac Rhythm Management Devices World MarketsPicture Archiving and Communications Systems (PACS)Biomarker Technology Platforms for Cancer Diagnoses and TherapiesCancer Diagnostic Testing World MarketsPositron Emission Tomography (PET) MarketsMolecular Diagnostics MarketsMolecular Diagnostics in Cancer TestingDrugs of Abuse Testing MarketsUltrasound MarketsNuclear Cardiology MarketsMedical Imaging BundleCancer Vaccines MarketsEuropean Medical Imaging MarketsRespiratory Therapeutics and Devices MarketsDiagnostics BundleMammography World Markets
  5. 5. Indias In Vitro Diagnostic Testing IndustryOrthopedics MarketsCell-Based Assays for Drug DiscoveryCytology and HPV Testing World MarketsClinical Chemistry AnalyzersClinical Immunoanalyzer MarketsMicroscopy MarketsAutomated Microbial Testing MarketsAnti-Infective Drugs MarketsPlastic Surgery Markets